Gossamer Bio

GOSSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$71.501 M

$11.69 +3.64%

Close of 22 Sept 2026

Revenue

$48.5M

#2741 by revenue

Earnings

-$170.4M

Loss-making

Shares outstanding

488,846,722

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#329CingulateCING$74.8M
#330Tenax TherapeuticsTENX$72.6M
#331Gossamer BioGOSS$71.5M
#332Pliant TherapeuticsPLRX$70.6M
#333MindWalkHYFT$69.7M

What if Gossamer Bio were worth as much as…

Open the what-if tool →

Gold $30.2T

$4,943,106

Per share 422,849× higher

Bitcoin $1.74T

$284,752.08

Per share 24,359× higher

Nvidia $5.52T

$901,800.91

Per share 77,143× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Gossamer Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.